Rift Valley fever (RVF) is a zoonotic, viral, vector-borne disease representing a threat to human health, animal health and livestock production in Africa, the Near East and potentially, Europe and the rest of the world. Rift Valley fever primarily affects sheep, goats, cattle, camels, buffaloes, and antelopes. The majority of human infections result from contact with the blood or organs of infected animals. The socioeconomic impact of the disease on people’s livelihoods and on trade can be high due to significant losses in livestock production (meat and milk), closure of livestock markets and bans on livestock movement and slaughtering. In Kenya, the RVF epidemic that occurred in 2006–2007 induced estimated losses to the economy of more than 2.1 billion Kenyan Shillings (USD32 million) and extended to various stakeholders in the marketing chain (Rich and Wanyioke, 2010). Other negative impacts included losses in production, increases in unemployment, and a reduction in operating capital among slaughterhouses and butchers.